DWS
VRTX icon

Dynamic Wealth Strategies’s Vertex Pharmaceuticals VRTX Stock Holding History

Dynamic Wealth Strategies’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.82K Hold
22
– – 0.01% 227
2025
Q4 		$9.97K Hold
22
– – 0.01% 214
2025
Q3 		$8.62K Hold
22
– – 0.01% 209
2025
Q2 		$9.79K Hold
22
– – 0.01% 198
2025
Q1 		$10.7K Buy
+22
New +$10.3K 0.01% 189
2024
Q4 		– Sell
-22
Closed -$10K – 217
2024
Q3 		$10K Hold
22
– – 0.01% 193
2024
Q2 		$10K Sell
22
-10
-31% -$4.34K 0.01% 196
2024
Q1 		$13K Hold
32
– – 0.01% 195
2023
Q4 		$13K Buy
+32
New +$11.8K 0.01% 189

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Dynamic Wealth Strategies's VRTX Position: Q1 2026 in Review

Dynamic Wealth Strategies held its Vertex Pharmaceuticals (VRTX) position steady in Q1 2026 at 22 shares worth $9.82K. The position accounts for 0.01% of the portfolio, ranked #227.

Dynamic Wealth Strategies first reported a position in VRTX in Q4 2023 and has held it in 9 quarters since. The position peaked at $13K in Q4 2023. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Dynamic Wealth Strategies held 22 shares of Vertex Pharmaceuticals worth $9.82K as of Q1 2026.
  • Dynamic Wealth Strategies left its Vertex Pharmaceuticals share count unchanged in Q1 2026.
  • Vertex Pharmaceuticals made up 0.01% of Dynamic Wealth Strategies's portfolio in Q1 2026, its #227 holding.
  • Dynamic Wealth Strategies first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 9 quarters since.
  • Dynamic Wealth Strategies's Vertex Pharmaceuticals position peaked at $13K in Q4 2023.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Dynamic Wealth Strategies's 13F filing for Q1 2026, filed 13 May 2026.